Announcements Trials

Browse Landscape

Status

No longer available 1

Sponsor Class

Study Type

Interventional 38 Observational 4 Expanded_access 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1

Interventions

elotuzumab 4 Bortezomib 4 Lenalidomide 3 Dexamethasone 3 talquetamab 2 selinexor 2 pomalidomide 2 carfilzomib 2 Panobinostat 2 venetoclax 1 ulocuplumab 1 plerixafor 1 idecabtagene vicleucel 1 fludarabine phosphate 1 daratumumab 1 ceritinib 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Tacrolimus 1 Prednisone 1 Mycophenolic Acid 1 Melphalan 1 Cytarabine 1 Crizotinib 1 Cord Blood Stem Cell Transplantation 1 Calcium Dobesilate 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × plerixafor × Plasma cell × Clear all

NCT00720603 2015-03-24

EAP

Sanofi

No longer available

LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡